Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM

BackgroundAdoptive transfer of tumor infiltrating or circulating lymphocytes transduced with tumor antigen receptors has been examined in various clinical trials to treat human cancers. The tumor antigens targeted by transferred lymphocytes affects the efficacy of this therapeutic approach.

http://ift.tt/1LA6X2D